L519 (Carbidopa and Levodopa Extended-Release 25 mg / 100 mg)
Pill with imprint L519 is Purple, Elliptical/Oval and has been identified as Carbidopa and Levodopa Extended-Release 25 mg / 100 mg. It is supplied by Alembic Pharmaceuticals Inc.
Carbidopa/levodopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for L519
Carbidopa and Levodopa Extended-Release
- Imprint
- L519
- Strength
- 25 mg / 100 mg
- Color
- Purple
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Alembic Pharmaceuticals Inc.
- National Drug Code (NDC)
- 62332-0332
Related images for "L519"
More about carbidopa / levodopa
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (85)
- Drug images
- Compare alternatives
- Pricing & coupons
- Drug class: dopaminergic antiparkinsonism agents
Patient resources
- Drug Information
- Carbidopa and levodopa enteral
- Carbidopa and levodopa (Advanced Reading)
- Carbidopa and Levodopa Extended-Release Tablets
- Carbidopa and Levodopa Orally Disintegrating Tablets
Other brands
Sinemet, Rytary, Duopa, Sinemet CR, Parcopa
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.